More recent understanding has highlighted that vulnerability of cancer cells to HSP90 inhibitors depends upon pathologic hyperconnectivity within the “epichaperome”, composed of chaperone and co-chaperone complexes, this has been characterized for solid cancers59,70, as well as for T-ALL29. Here, AQP1 is linked to cancer.